Atlas Brown’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $564K | Hold |
1,071
| – | – | 0.15% | 136 |
|
|
2026
Q1 | $602K | Buy |
1,071
+179
| +20% | +$115K | 0.18% | 116 |
|
|
2025
Q4 | $604K | Sell |
892
-6
| -0.7% | -$4.09K | 0.18% | 113 |
|
|
2025
Q3 | $574K | Sell |
898
-40
| -4% | -$24.3K | 0.17% | 118 |
|
|
2025
Q2 | $503K | Sell |
938
-3
| -0.3% | -$1.44K | 0.16% | 127 |
|
|
2025
Q1 | $395K | Hold |
941
| – | – | 0.14% | 144 |
|
|
2024
Q4 | $389K | Hold |
941
| – | – | 0.13% | 145 |
|
|
2024
Q3 | $475K | Buy |
941
+1
| +0.1% | +$486 | 0.16% | 128 |
|
|
2024
Q2 | $458K | Buy |
940
+3
| +0.3% | +$1.51K | 0.16% | 123 |
|
|
2024
Q1 | $506K | Hold |
937
| – | – | 0.18% | 115 |
|
|
2023
Q4 | $520K | Hold |
937
| – | – | 0.22% | 110 |
|
|
2023
Q3 | $410K | Hold |
937
| – | – | 0.19% | 118 |
|
|
2023
Q2 | $471K | Hold |
937
| – | – | 0.21% | 115 |
|
|
2023
Q1 | $469K | Hold |
937
| – | – | 0.22% | 114 |
|
|
2022
Q4 | $382K | Hold |
937
| – | – | 0.19% | 127 |
|
|
2022
Q3 | $305K | Hold |
937
| – | – | 0.16% | 137 |
|
|
2022
Q2 | $329K | Sell |
937
-10
| -1% | -$4.08K | 0.16% | 135 |
|
|
2022
Q1 | $518K | Buy |
947
+10
| +1% | +$5.26K | 0.21% | 123 |
|
|
2021
Q4 | $617K | Hold |
937
| – | – | 0.24% | 117 |
|
|
2021
Q3 | $583K | Sell |
937
-93
| -9% | -$62.5K | 0.25% | 116 |
|
|
2021
Q2 | $650K | Hold |
1,030
| – | – | 0.28% | 105 |
|
|
2021
Q1 | $504K | Hold |
1,030
| – | – | 0.24% | 112 |
|
|
2020
Q4 | $515K | Hold |
1,030
| – | – | 0.27% | 103 |
|
|
2020
Q3 | $405K | Hold |
1,030
| – | – | 0.24% | 107 |
|
|
2020
Q2 | $340K | Hold |
1,030
| – | – | 0.22% | 112 |
|
|
2020
Q1 | $250K | Sell |
1,030
-30
| -3% | -$7.83K | 0.2% | 121 |
|
|
2019
Q4 | $277K | Hold |
1,060
| – | – | 0.17% | 128 |
|
|
2019
Q3 | $288K | Hold |
1,060
| – | – | 0.21% | 118 |
|
|
2019
Q2 | $292K | Sell |
1,060
-40
| -4% | -$9.86K | 0.2% | 115 |
|
|
2019
Q1 | $246K | Sell |
1,100
-55
| -5% | -$11.4K | 0.17% | 131 |
|
|
2018
Q4 | $215K | Sell |
1,155
-95
| -8% | -$19.5K | 0.17% | 132 |
|
|
2018
Q3 | $312K | Sell |
1,250
-150
| -11% | -$36.4K | 0.19% | 117 |
|
|
2018
Q2 | $328K | Sell |
1,400
-54
| -4% | -$11.1K | 0.08% | 114 |
|
|
2018
Q1 | $278K | Hold |
1,454
| – | – | 0.05% | 125 |
|
|
2017
Q4 | $268K | Hold |
1,454
| – | – | 0.05% | 126 |
|
|
2017
Q3 | $226K | Hold |
1,454
| – | – | 0.05% | 122 |
|
|
2017
Q2 | $235K | Hold |
1,454
| – | – | 0.21% | 116 |
|
|
2017
Q1 | $225K | Buy |
+1,454
| New | +$200K | 0.18% | 117 |
|
Other funds holding IDXX
Atlas Brown's IDXX Position: Q2 2026 in Review
Atlas Brown held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 1,071 shares worth $564K. The position accounts for 0.15% of the portfolio, ranked #136.
Atlas Brown first reported a position in IDXX in Q1 2017 and has held it in 38 quarters since. The position peaked at $650K in Q2 2021. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Atlas Brown held 1,071 shares of Idexx Laboratories worth $564K as of Q2 2026.
- Atlas Brown left its Idexx Laboratories share count unchanged in Q2 2026.
- Idexx Laboratories made up 0.15% of Atlas Brown's portfolio in Q2 2026, its #136 holding.
- Atlas Brown first reported a position in Idexx Laboratories in Q1 2017 and has held it in 38 quarters since.
- Atlas Brown's Idexx Laboratories position peaked at $650K in Q2 2021.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Atlas Brown's 13F filing for Q2 2026, filed 9 Jul 2026.